Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: P-362 Role of mitogen-activated protein kinase (MAPK) and AKT as predictive factors for response to ZD 1839 therapy in non-small cell lung cancer (NSCLC) patients, Lung Cancer, August 2003, Elsevier,
DOI: 10.1016/s0169-5002(03)92330-0.
You can read the full text:
Contributors
The following have contributed to this page